Next Article in Journal
Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
Next Article in Special Issue
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
Previous Article in Journal
Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
Previous Article in Special Issue
Specific Inhibition of HIF Activity: Can Peptides Lead the Way?
 
 
Review

Article Versions Notes

Cancers 2021, 13(5), 988; https://doi.org/10.3390/cancers13050988
Action Date Notes Link
article xml file uploaded 27 February 2021 08:12 CET Original file -
article xml uploaded. 27 February 2021 08:12 CET Update -
article pdf uploaded. 27 February 2021 08:12 CET Version of Record https://www.mdpi.com/2072-6694/13/5/988/pdf-vor
article html file updated 27 February 2021 08:14 CET Original file -
article xml file uploaded 2 March 2021 13:00 CET Update -
article xml uploaded. 2 March 2021 13:00 CET Update https://www.mdpi.com/2072-6694/13/5/988/xml
article pdf uploaded. 2 March 2021 13:00 CET Updated version of record https://www.mdpi.com/2072-6694/13/5/988/pdf
article html file updated 2 March 2021 13:02 CET Update -
article html file updated 25 July 2022 05:19 CEST Update https://www.mdpi.com/2072-6694/13/5/988/html
Back to TopTop